SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BARONI, Marcello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.532
AS - Asia 2.188
EU - Europa 1.485
SA - Sud America 416
AF - Africa 36
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.672
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.415
SG - Singapore 898
CN - Cina 637
IT - Italia 363
BR - Brasile 338
DE - Germania 303
HK - Hong Kong 210
GB - Regno Unito 170
UA - Ucraina 170
VN - Vietnam 156
TR - Turchia 110
PL - Polonia 90
FI - Finlandia 69
RU - Federazione Russa 68
SE - Svezia 63
CA - Canada 61
ID - Indonesia 48
MX - Messico 44
FR - Francia 37
AR - Argentina 32
NL - Olanda 31
BE - Belgio 30
IN - India 30
ES - Italia 27
BD - Bangladesh 22
JP - Giappone 21
ZA - Sudafrica 20
CZ - Repubblica Ceca 18
EC - Ecuador 18
AT - Austria 12
LT - Lituania 12
PE - Perù 12
AU - Australia 11
IQ - Iraq 8
PK - Pakistan 8
MA - Marocco 7
AZ - Azerbaigian 6
RO - Romania 6
CO - Colombia 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
KE - Kenya 4
GE - Georgia 3
GT - Guatemala 3
IR - Iran 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
CL - Cile 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
IE - Irlanda 2
JO - Giordania 2
KR - Corea 2
MY - Malesia 2
PT - Portogallo 2
SA - Arabia Saudita 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
IS - Islanda 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 8.672
Salva come PNG Salva come JPEG
Città #
Singapore 524
Ashburn 435
Fairfield 383
Woodbridge 361
Chandler 274
Beijing 241
Santa Clara 231
Houston 212
Hong Kong 208
Dallas 202
Ann Arbor 190
Ferrara 180
Jacksonville 168
Seattle 167
Wilmington 152
Cambridge 123
Munich 92
The Dalles 92
New York 86
Warsaw 84
Los Angeles 80
Boardman 76
Izmir 66
Nanjing 59
Princeton 56
Ho Chi Minh City 46
Jakarta 41
Milan 40
Dearborn 37
Shanghai 36
Hanoi 34
Bremen 32
San Diego 31
São Paulo 31
Mexico City 30
Brooklyn 25
Brussels 25
Falls Church 23
Nanchang 22
Shenyang 22
Turku 22
Hefei 21
Tokyo 19
Buffalo 18
London 18
Denver 17
Moscow 17
Toronto 17
Brno 16
Chicago 16
Montreal 16
Poplar 16
Redwood City 16
Florence 15
Hebei 14
Helsinki 14
Norwalk 14
Dong Ket 13
Frankfurt am Main 13
Johannesburg 13
Manchester 13
Orem 13
Boston 12
Guangzhou 12
Jiaxing 12
Tianjin 12
Amsterdam 11
Mcallen 11
Phoenix 10
Verona 10
Zhengzhou 10
Atlanta 9
Chennai 9
Columbus 9
Düsseldorf 9
Rome 9
San Francisco 9
San Mateo 9
Haiphong 8
Montréal 8
Quito 8
Auburn Hills 7
Bologna 7
Des Moines 7
Dortmund 7
Lima 7
Rio de Janeiro 7
Stockholm 7
Abdullah 6
Augusta 6
Baku 6
Changsha 6
Charlotte 6
Easley 6
Mumbai 6
North Bergen 6
Ottawa 6
Ribeirão Preto 6
Belo Horizonte 5
Biên Hòa 5
Totale 5.874
Salva come PNG Salva come JPEG
Nome #
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 245
Hemostasis biomarkers in multiple sclerosis 228
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 218
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 208
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 205
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 203
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 197
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 195
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 182
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 182
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 181
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 179
Membrane binding and anticoagulant properties of protein S natural variants 179
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 178
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 168
Plasma levels of soluble NCAM in multiple sclerosis 167
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 164
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 161
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 159
Apolipoprotein C-III Strongly Correlates with Activated Factor VII-Anti-Thrombin Complex: An Additional Link between Plasma Lipids and Coagulation 154
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 152
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 152
Activated factor VII: antithrombin complex plasma concentration in subjects with or without angiographically demonstrated coronary artery disease and myocardial infarction 147
Expression profiles of the internal jugular and saphenous veins: Focus on hemostasis genes 147
Impaired prothrombinase activity of factor X Gly381 Asp results in severe familial CRM+ FX deficiency 142
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 138
Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis 137
Functional recovery in multiple sclerosis patients undergoing rehabilitation programs is associated with plasma levels of hemostasis inhibitors 136
The F7 p.Val22Ile missense mutation affects splicing and can be counteracted by a compensatory U1snRNA 134
Reduced activation of the Gla19Ala FX variant via the extrinsic coagulation pathway results in symptomatic CRMred FX deficiency 133
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 126
Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients 126
Release of Tissue Factor-bearing microparticles by human dendritic cells induced by stimulation of membrane P2X7 receptors 124
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 123
Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques? 122
Non-conventional therapeutic strategies for inherited disorders of hemostasis 121
RNA-based therapeutic approaches for blood coagulation factor deficiencies caused by a splicing mutations 119
Hemostasis gene expression of the internal jugular and saphenous veins 118
THE NATURAL ARG386CYS MUTATION IN THE COAGULATION FACTOR X, AS A TOOL TO INVESTIGATE DIFFERENT FX-REQUIREMENTS IN INITIATION AND PROPAGATION PHASES. 115
CCL18 plasma levels are increased in progressive MS patients and associated with MRI outcomes of tissue injury (P1.396) 114
Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis 113
In Situ Endothelial SARS-CoV-2 Presence and PROS1 Plasma Levels Alteration in SARS-CoV-2-Associated Coagulopathies 108
Natural mutations in the EGF4 domain of protein S produce extended conformational changes and alter phospholipid and C4bBP interactions 103
EFFECT OF SARS-CoV-2 ON THE COAGULATION CASCADE IN COVID-19 ASSOCIATED COAGULOPATHIES 97
Tratamiento y profilaxis de trastornos cardiovasculares con ácido erúcico 96
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 96
null 94
null 93
West Nile virus non-structural protein 1 promotes amyloid Beta deposition and neurodegeneration 92
Combination of Genomic and Transcriptomic Approaches Highlights Vascular and Circadian Clock Components in Multiple Sclerosis 91
NATURAL MUTATIONS IN THE EGF4 DOMAIN OF PROTEIN S PRODUCE EXTENDED CONFORMATIONAL CHANGES AND ALTER PHOSPHOLIPID AND C4BBP INTERACTIONS 91
The effect of the chemical chaperone 4-phenylbutyrate on secretion and activity of the p.Q160R missense variant of coagulation factor FVII 91
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 90
Aptamer-modified FXa generation assays to investigate hypercoagulability in plasma from patients with ischemic heart disease 89
The Factor VII Variant p.A354V-p.P464Hfs: Clinical versus Intracellular and Biochemical Phenotypes Induced by Chemical Chaperones 88
null 84
Molecular characterization of factor X deficiency associated with borderline plasma factor X level 83
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 80
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 75
null 73
Mapping of inhibitory antibodies directed to the carboxy-terminus of FVIIa in severe FVII deficiency with elongated C-terminal variant (p.A354V-p.P464Hfs†) 70
Plasma levels of hemostasis inhibitors and MRI outcomes in multiple sclerosis (P3.368) 68
Coagulation factor VII variants resistant to inhibitory antibodies 68
Immune response to treatment in a severe factor VII deficient patient: characterization of the inhibitory antibody and epitope-mapping 66
Coagulation factor VII variants resistant to inhibitory antibodies. 62
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 61
null 56
Relationships among circulating levels of hemostasis inhibitors, chemokines, adhesion molecules, and mri characteristics in multiple sclerosis 51
Treatment and prophylaxis of cardiovascular disorders with erucic acid and related diagnostic methods 50
null 45
Natural Mutations in the 4th EGF-Like Domain of Protein S Alter GLA and SHBG Domain Interactions. 18
Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis 13
Flavivirus Nonstructural Protein 1-Driven Coagulation via Tissue Factor-Bearing Microvesicles: A Pilot Study 1
Totale 8.835
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.261
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.261
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021582 0 0 0 0 0 58 81 80 50 145 123 45
2021/2022636 84 70 22 28 24 29 26 35 18 49 44 207
2022/2023634 60 64 23 87 92 88 46 50 67 8 37 12
2023/2024436 27 33 15 10 32 64 22 48 12 16 10 147
2024/20251.565 33 41 143 47 170 153 33 61 254 210 235 185
2025/20262.666 491 249 476 626 756 68 0 0 0 0 0 0
Totale 8.835